News
AIC and EXTEN Technologies to Provide NVMe-oF Storage Solutions with the Same Ultra-high Performance as Direct Connected NVMe
Taipei, Taiwan, May 23, 2019 – AIC and EXTEN Technologies have partnered to provide a complete NVMe-oF target solution using a cost-effective FBOF platform running Broadcom PS1100R Stingray 100G SmartNIC with EXTEN HyperDynamic Software. The AIC J2024-04 platform supports twice the PCIe bandwidth of a typical 2U server, allowing quad
Read More
GTxcel Announces Upgraded Turnstyle Platform
GTxcel is excited to announce the release of the next generation of Turnstyle. Our upgraded publishing platform combines automation and design control to create a completely responsive digital edition in just hours. Provide your readers with a superior user experience across devices and screen sizes – while you open the
Read MoreGTxcel celebrates WCAG 2.0 A & AA Certification
After months of rigorous testing, GTxcel is proud to announce that the Turnstyle platform is officially Web Content Accessibility Guidelines (WCAG) 2.0 certified at the A & AA level. This means that the Turnstyle platform has met a series of success criteria as set forth by the Web Accessibility Initiative (WAI) of the World Wide Web
Read MoreFebruary 2019 Updates: Search, Analytics and Library
Analytics We have updated the Analytics dashboard. You may notice that we have revised some of the definitions and removed the percent of increase on the Issue tab. Library Updates The Library has been updated. The new Library will move search to the top and all issues will show uniformly
Read MoreMarch Product Updates – Advertising & Analytics
March may be winding down but the team here at GTxcel is enjoying the madness and is in full swing executing many exciting new features for you. Here are a few of the items we are working on. Advertisements As the world continues to become more mobile, so should your
Read MoreTurnstyle Publishing Platform Engagement Statistics
We launched the Turnstyle platform with the hypothesis that we could help publishers engage readers with a much more efficient workflow than other products in the market, including Adobe’s Digital Publishing Suite (DPS). Prior to January, Turnstyle support was limited to native apps and resulted in about a 40% increase in
Read More
Mota Bhai, Let’s Listen to the Messages from NOTA
In India, NOTA i.e., ‘None of the Above’ was introduced as a choice for the Electronic Voting Machines and Postal Ballots in the General Elections in 2014. It is widely accepted that a NOTA vote is lack of endorsement by the voter for any of the candidates contesting in a
Read MoreThe Consumer Centric Behavior of Indian Stock Markets
Gross Domestic Product (GDP) is the sum of Consumption (C), Government Spending (G), Savings (S) and the difference of Exports and Imports (X – M). Mathematically, GDP = C + G + S + X – M. Different countries exhibit different characteristics in GDP and GDP growth. For example, in
Read More
TherOx Receives FDA Approval for the First Heart Attack Treatment Since PCI to Reduce Infarct Size
View Full Press Release >>
Read More
Oppilan Pharma Initiates Phase 1 Clinical Study with OPL-002
A novel S1P1 modulator for the treatment of inflammatory bowel disease ENCINITAS, California and Cambridge, United Kingdom, January 7, 2019 – Oppilan Pharma Ltd, a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for the treatment of autoimmune diseases, today announced that it has completed dosing of the
Read More
ProterixBio, Inc. presenting at Biotech Showcase™ 2019
ProterixBio, Inc. will be attending Biotech Showcase™ 2019, to be held January 7-9th at the Hilton San Francisco Union Square. Biotech Showcase™, along with the Digital Medicine and Medtech Showcase, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an
Read More
Icosabutate latest data shows direct and potent anti-fibrotic effect in both differentiated rodent NASH models and human stellate cells
Results to be presented at the AASLD congress 2018, 9-13 November In a biopsy-confirmed fibrotic ob/ob NASH mouse model, icosabutate reduced hepatic fibrosis in association with a 45% decrease in myofibroblast content in pre- versus post-treatment liver biopsies In a CDAA NASH mouse model, icosabutate reduced fibrosis levels to baseline
Read More